Edmond de Rothschild Asset Management (France)’s Regeneron Pharmaceuticals REGN Stock Holding History

Edmond de Rothschild Asset Management (France)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$8.04M	Hold	20,000	–	–	0.35%	71
2016 Q2	$6.99M	Hold	20,000	–	–	0.31%	76
2016 Q1	$7.21M	Hold	20,000	–	–	0.31%	87
2015 Q4	$10.9M	Hold	20,000	–	–	0.38%	74
2015 Q3	$9.3M	Hold	20,000	–	–	0.31%	77
2015 Q2	$10.2M	Buy	+20,000	New	+$9.76M	0.27%	80

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Edmond de Rothschild Asset Management (France)'s REGN Position: Q3 2016 in Review

Edmond de Rothschild Asset Management (France) held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2016 at 20,000 shares worth $8.04M. The position accounts for 0.35% of the portfolio, ranked #71.

Edmond de Rothschild Asset Management (France) first reported a position in REGN in Q2 2015 and has held it in 6 quarters since. The position peaked at $10.9M in Q4 2015. 554 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

Edmond de Rothschild Asset Management (France) held 20,000 shares of Regeneron Pharmaceuticals worth $8.04M as of Q3 2016.
Edmond de Rothschild Asset Management (France) left its Regeneron Pharmaceuticals share count unchanged in Q3 2016.
Regeneron Pharmaceuticals made up 0.35% of Edmond de Rothschild Asset Management (France)'s portfolio in Q3 2016, its #71 holding.
Edmond de Rothschild Asset Management (France) first reported a position in Regeneron Pharmaceuticals in Q2 2015 and has held it in 6 quarters since.
Edmond de Rothschild Asset Management (France)'s Regeneron Pharmaceuticals position peaked at $10.9M in Q4 2015.
554 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q3 2016, filed 14 Nov 2016.